BridgeMD
New treatment option for Cesarean Delivery
Official title A RCT of Labor Induction at 39 Weeks in Low - Risk Women in China
ClinicalTrials.gov ID: NCT07082530
What this study is testing
- What it's testing
- The investigators are committed to identifying the optimal timing of delivery for low-risk pregnancies. While current guidelines typically recommend induction at 41 weeks, emerging evidence suggests that elective induction at 39 weeks may lead to improved maternal and neonatal outcomes.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older, women only. Healthy volunteers may be eligible.
You may be able to join if
- Age ≥18 years.
- Singleton pregnancy or twin pregnancy reduced to singleton before 14 weeks.
- Gestational age between 38 weeks 4 days or 38 weeks 6 days at randomization.
- Eligible for vaginal delivery with a desire for vaginal birth.
- Reliable gestational age determination.
You likely can't join if
- First-trimester ultrasound estimate \>13 weeks 6 days.
- Planned induction before 41 weeks.
- Planned cesarean delivery or contraindications to vaginal delivery.
- Already delivered, in labor, or ruptured membranes at enrollment.
- Placenta previa, vasa previa, placenta accreta, or placental abruption.
- Contraindications to induction (e.g., cervical cancer, history of uterine rupture, genital tract malformations, abnormal fetal position, cord...
See the full eligibility criteria
- Age ≥18 years.
- Singleton pregnancy or twin pregnancy reduced to singleton before 14 weeks.
- Gestational age between 38 weeks 4 days or 38 weeks 6 days at randomization.
- Eligible for vaginal delivery with a desire for vaginal birth.
- Reliable gestational age determination.
- Maternal and fetal conditions assessed as low-risk by at least two senior obstetricians, with no indications requiring delivery before 41 weeks.
- Ability to understand study information and provide informed consent.
- First-trimester ultrasound estimate \>13 weeks 6 days.
- Planned induction before 41 weeks.
- Planned cesarean delivery or contraindications to vaginal delivery.
- Already delivered, in labor, or ruptured membranes at enrollment.
- Placenta previa, vasa previa, placenta accreta, or placental abruption.
- Contraindications to induction (e.g., cervical cancer, history of uterine rupture, genital tract malformations, abnormal fetal position, cord prolapse).
- Active vaginal bleeding exceeding spotting.
- History of cesarean delivery or uterine/cervical surgery.
- Cervical cerclage during this pregnancy.
- Maternal conditions not suitable for expectant management beyond 39 weeks (e.g., pregestational diabetes, gestational diabetes requiring insulin, hypertensive disorders, intrahepatic cholestasis of pregnancy).
- Fetal conditions not suitable for expectant management beyond 39 weeks (e.g., fetal death, major anomalies, growth restriction, macrosomia, anemia, oligohydramnios, polyhydramnios).
- Maternal infections or positive screenings for sexually transmitted pathogens or group B Streptococcus.
- Planned delivery at a non-study facility.
- Participation in another intervention study affecting delivery management.
The study team makes the final eligibility decision.
Where it's taking place
- Hangzhou, Zhejiang, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years and older. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Hangzhou, Zhejiang, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.